Patents by Inventor THERAMAB GMBH

THERAMAB GMBH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF AN ACTIVE SUBSTANCE BINDING TO CD28 FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF B-CLL
    Publication number: 20130078257
    Abstract: The invention relates to the use of a superagonistic monoclonal antibody (mAb), which is specific for a naturally costimulatory receptor expressed on T cells, or a mimicry compound thereto, for producing a pharmaceutical composition for the treatment of diseases occurring with lacking costimulability of T cells, in particular of the B-CLL.
    Type: Application
    Filed: September 24, 2012
    Publication date: March 28, 2013
    Applicant: THERAMAB GMBH
    Inventor: THERAMAB GMBH